Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Medical Foods Market: By Therapeutic Type, By Mode of Administration, By Application, By Distribution Channel and Geography
Medical foods Market size was valued at $ 17.03 billion in 2023 and is anticipated to grow at $ 29.67 billion by 2030 recording a CAGR of 6.5% from 2024-2030. Foods that are subjected to technological modifications either for protection or for changing over into prepared-to-utilize/eat nourishments, disposing of relentless family unit strategies, are called Medical Foods A portion of the cases is processed blends, dried-out nourishments, pasta items, canned food, confectionery, pastry shop, dairy items, and breakfast nourishments. Manufacture of Medical Foods requires innovative applications and apparatus, and thus, Medical Foods are costly.
Modern players are engaged with the securing of little players which will additionally bolster the organization to grow and contact shoppers over the areas, the end-client enterprises are slanted towards item advancements through online life, magazines, and different mediums keeping in mind the end goal to connect with clients. The limited time methodology helps in holding the current clients and furthermore to recover new client base. With vital extensions, advertise players can center around entering into the creating economies to extend their business portfolio. Customers in creating nations are excited about investigating new item runs offered to them and framing a substantial purchaser base. Setting up showcases in these rising economies is beneficial in view of moderately low set-up costs, simplicity of working together, and further lower variable cost to be caused.
Study Period
2024-2030Base Year
2023CAGR
6.5%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
The worldwide Medical Foods market is driven by an ascent in geriatric populace and increment in risk of chronic ailments around the world. There is a moving pattern toward enteral nourishment (ingestion through the gastrointestinal tract) parenteral nutrition absorption such as intravenous administration, for example, intravenous organization. The enteral organization is more secure when contrasted with the parenteral choice as there is a lesser danger of disease and it offers physiological benefits, for example, the upkeep of small digestive system mass and pancreatic capacity. Mechanical progressions have decreased the cost of enteral medication organization, influencing it to cost-effective. Hence, a move toward medical food and increment in demand for customized prescription in created nations are relied upon to fuel interest for medicinal foods sooner rather than later.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
6.5% |
By Therapeutic Type |
|
By Route of Administrat |
|
By Application |
|
By Distribution Channel |
|
Download Free Sample Report
The medical foods market size was valued at $ 17.03 billion in 2023.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
The medical foods market key players are: Danone SA (France), Nestle SA (Switzerland), Abbott Laboratories (U.S.), Mead Johnson & Company, LLC (U.S.), Primus Pharmaceuticals Inc. (U.S.), Targeted Medical Pharma Inc. (U.S.), Fresenius Kabi AG (Germany)
1.Executive Summary |
2.Global Medical Foods Market Introduction |
2.1.Global Medical Foods Market - Taxonomy |
2.2.Global Medical Foods Market - Definitions |
2.2.1.Therapeutic Type |
2.2.2.Mode of Administration |
2.2.3.Application |
2.2.4.Distribution Channel |
2.2.5.Region |
3.Global Medical Foods Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Medical Foods Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Medical Foods Market By Therapeutic Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Pain Management, Sleep Management |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Obesity and Hypertension |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Cognitive Disorders |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Viral Infections |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Neuro-Degenerative Disorders |
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Inborn Errors of Metabolism |
5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6.Global Medical Foods Market By Mode of Administration, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Parenteral |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Enteral |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Medical Foods Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Diabetic Neuropathy |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. ADHD |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Depression |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Alzheimers Disease |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Nutritional Deficiency |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Medical Foods Market By Distribution Channel, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Hospital Pharmacy |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Retail Pharmacy |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Online Pharmacy |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Medical Foods Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Medical Foods Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Therapeutic Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Pain Management, Sleep Management |
10.1.2.Obesity and Hypertension |
10.1.3.Cognitive Disorders |
10.1.4.Viral Infections |
10.1.5.Neuro-Degenerative Disorders |
10.1.6.Inborn Errors of Metabolism |
10.2. Mode of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Parenteral |
10.2.2.Enteral |
10.2.3.Others |
10.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Diabetic Neuropathy |
10.3.2.ADHD |
10.3.3.Depression |
10.3.4.Alzheimer’s Disease |
10.3.5.Nutritional Deficiency |
10.4. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospital Pharmacy |
10.4.2.Retail Pharmacy |
10.4.3.Online Pharmacy |
10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Medical Foods Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Therapeutic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Pain Management, Sleep Management |
11.1.2.Obesity and Hypertension |
11.1.3.Cognitive Disorders |
11.1.4.Viral Infections |
11.1.5.Neuro-Degenerative Disorders |
11.1.6.Inborn Errors of Metabolism |
11.2. Mode of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Parenteral |
11.2.2.Enteral |
11.2.3.Others |
11.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Diabetic Neuropathy |
11.3.2.ADHD |
11.3.3.Depression |
11.3.4.Alzheimer’s Disease |
11.3.5.Nutritional Deficiency |
11.4. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospital Pharmacy |
11.4.2.Retail Pharmacy |
11.4.3.Online Pharmacy |
11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Medical Foods Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Therapeutic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Pain Management, Sleep Management |
12.1.2.Obesity and Hypertension |
12.1.3.Cognitive Disorders |
12.1.4.Viral Infections |
12.1.5.Neuro-Degenerative Disorders |
12.1.6.Inborn Errors of Metabolism |
12.2. Mode of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Parenteral |
12.2.2.Enteral |
12.2.3.Others |
12.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Diabetic Neuropathy |
12.3.2.ADHD |
12.3.3.Depression |
12.3.4.Alzheimers Disease |
12.3.5.Nutritional Deficiency |
12.4. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospital Pharmacy |
12.4.2.Retail Pharmacy |
12.4.3.Online Pharmacy |
12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Medical Foods Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Therapeutic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Pain Management, Sleep Management |
13.1.2.Obesity and Hypertension |
13.1.3.Cognitive Disorders |
13.1.4.Viral Infections |
13.1.5.Neuro-Degenerative Disorders |
13.1.6.Inborn Errors of Metabolism |
13.2. Mode of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Parenteral |
13.2.2.Enteral |
13.2.3.Others |
13.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Diabetic Neuropathy |
13.3.2.ADHD |
13.3.3.Depression |
13.3.4.Alzheimers Disease |
13.3.5.Nutritional Deficiency |
13.4. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospital Pharmacy |
13.4.2.Retail Pharmacy |
13.4.3.Online Pharmacy |
13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Medical Foods Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
14.1. Therapeutic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Pain Management, Sleep Management |
14.1.2.Obesity and Hypertension |
14.1.3.Cognitive Disorders |
14.1.4.Viral Infections |
14.1.5.Neuro-Degenerative Disorders |
14.1.6.Inborn Errors of Metabolism |
14.2. Mode of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Parenteral |
14.2.2.Enteral |
14.2.3.Others |
14.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Diabetic Neuropathy |
14.3.2.ADHD |
14.3.3.Depression |
14.3.4.Alzheimer’s Disease |
14.3.5.Nutritional Deficiency |
14.4. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospital Pharmacy |
14.4.2.Retail Pharmacy |
14.4.3.Online Pharmacy |
14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Danone SA (France) |
15.2.2.Nestle SA (Switzerland) |
15.2.3.Abbott Laboratories (U.S.) |
15.2.4.Mead Johnson & Company, LLC (U.S.) |
15.2.5.Primus Pharmaceuticals Inc. |
15.2.6.Targeted Medical Pharma Inc. (U.S.) |
15.2.7.Fresenius Kabi AG (Germany) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players